↓ Skip to main content

Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective

Overview of attention for article published in Frontiers in oncology, March 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
5 X users

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective
Published in
Frontiers in oncology, March 2021
DOI 10.3389/fonc.2021.636068
Pubmed ID
Authors

María Belen Marzal-Alfaro, Vicente Escudero-Vilaplana, Jose Luis Revuelta-Herrero, Roberto Collado-Borrell, Ana Herranz-Alonso, Maria Sanjurjo-Saez

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 13%
Other 3 8%
Student > Master 3 8%
Student > Bachelor 3 8%
Unspecified 2 5%
Other 3 8%
Unknown 20 51%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 6 15%
Medicine and Dentistry 6 15%
Unspecified 2 5%
Biochemistry, Genetics and Molecular Biology 1 3%
Economics, Econometrics and Finance 1 3%
Other 1 3%
Unknown 22 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2021.
All research outputs
#14,706,076
of 25,643,886 outputs
Outputs from Frontiers in oncology
#3,811
of 22,758 outputs
Outputs of similar age
#211,868
of 454,006 outputs
Outputs of similar age from Frontiers in oncology
#223
of 1,000 outputs
Altmetric has tracked 25,643,886 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,758 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,006 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 1,000 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.